GLUE

MONTE ROSA THERAPEUTICS INC

Healthcare | Small Cap

-$0.28

EPS Forecast

$21.23

Revenue Forecast

The company already released most recent quarter's earnings. We will publish our AI's next quarter's forecast around 2026-07-01

Proximilar's AI forecasts

EPS Forecast:

-$0.28

Revenue Forecast:

$21.23

EPS Surprise Forecast:

$0.010

Revenue Surprise Forecast:

$0

Post-release price volatility - Very high

Post-release Overnight Move:

±10.0%

Post-release 1-week Move:

±

Odds of beating consensus

Probability of beating EPS consensus:

55%

Probability of beating revenue consensus:

55%

Probability of beating both EPS & revs consensus:

37%

Probability of missing both EPS & revs consensus:

27%

Surprise rating (from -5 to 5)

How unusually large is the +/- surprise we forecast:

-3

Beta (β)

Forward Looking Beta (β):

1.30

Earnings volatility

EPS standard deviation:

$0.29

Revenue standard deviation:

$11

As % of share price:

1.82% VERY HIGH

As % of market cap:

0.88% MEDIUM

Confidence intervals and percentiles

EPS 95th %ile:

$0.09

Revenue 95th %ile:

$35

EPS 75th %ile:

-$0.18

Revenue 75th %ile:

$25

EPS 25th %ile:

-$0.36

Revenue 25th %ile:

$18

EPS 5th %ile:

-$0.61

Revenue 5th %ile:

$9

Correlation of surprises (strength of relationship)

Correlation between EPS & revenue surprises:

40% MEDIUM

Earnings sensitivity to revenue surprises (slope of regression line)

Expected % of revenue surprise going to EPS:

82% VERY HIGH

Stock's bid-ask spread

Bid-ask per $10K:

$20

Bid-ask per Share:

$0.03